[1] Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths [J]. CA Cancer J Clin, 2011,61(4):212-236. [2] 陈万青, 张思维, 孔灵芝, 等. 中国肿瘤登记处2004年恶性肿瘤死亡资料分析 [J]. 中国肿瘤, 2008,17(11):913-916. [3] Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008 [J]. CA Cancer J Clin, 2008,58(2):71-96. [4] 刘增军, 沈赞, 姚阳. 肿瘤干细胞的多样性起源及其相应机制的研究进展 [J]. 中国癌症杂志, 2011,21(3):236-240. [5] Karoubi G, Cortes-Dericks L, Gugger M, et al. Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma [J]. J Surg Oncol, 2010,102(6):689-698. [6] 陈杰, 白春学, 钱桂生, 等. A549/CDDP多药耐药细胞系的建立 [J]. 中国癌症杂志, 2003,13(2):186-187. [7] Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population [J]. Cell Death Differ, 2008,15(3):504-514. [8] Donnenberg VS, Donnenberg AD. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis [J]. J Clin Pharmacol, 2005,45(8):872-877. [9] Huntly BJ, Gilliland DG. Cancer biology: summing up cancer stem cells [J]. Nature, 2005,435(7046):1169-1170. [10] 李笑秋, 胡冰. 切除修复交叉互补基因1与消化系统肿瘤铂类耐药的关系研究进展 [J]. 中国临床药理学与治疗学, 2010,15(1):116-120. |